Journal of Clinical & Experimental Oncology has recently published a review of the technology based on clinical data related to cancer therapy.
Here is the link to access that article: Please select the PDF mode to view or download.
You'll note the B Batch contribution to the technology among the authors with Ranjit as the Head of Medical Research and myself as the leading care provider since 2006 with over 250 cases of advanced cancers and > 300 cases of cartilage regeneration in degenerative joint diseases involving knee and other joints as well as Spine.
I have a Centre in Bengaluru with two Cytotron devices including the new Whole Body Model and am treating cases regularly from all over
India, and a few places in the US, UK, Europe, Gulf and Africa.
A clinical trial facility is being created at the Johns Hopkins shortly for trials in Brain disorders including AD and Gliomas under the leadership of a Harvard & Johns Hopkins Professor of Neurovirology and Molecular Diseases:
Current ongoing research on regeneration of kidney in CRF, neurones in stroke & AD, and pancreas in DM are encouraging.
The fact that US treasury funds are made available for clinical trials and th
e Cytotron devices are being imported from Bengaluru waiving off the
FDA approval requirement for the Johns Hopkins trials is significant. The device is approved for Europe,
Malaysia,
Gulf, China, etc.
Will be glad to provide any more specific information on the clinical applications so far. Thank you for your attention.
Best regards
Dr GS Nayar
Chairman/Founder Director
Anytime Medicare Services
#257, 3rd Cross, 2nd Stage, 2nd Phase
Domlur, Bengaluru 560 071
+91 974 111 8867